CBIH Announces Patent-Related Scientific Framework for PTSD-Focused Cannabinoid and Psilocybin Research

CBIH announced the completion of patent-related work and a scientific framework linking cannabinoids and psilocybin to PTSD research. The company describes this as building a 'broader scientific foundation' for trauma-related research, focusing on stress response, neuroplasticity, and emotional regulation.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.